Science and Research

Oral Squamous Carcinoma Cells Express B7-H1 and B7-DC Receptors in Vivo

B7-H1 and B7-DC ligands are members of the B7 family with important regulatory functions in cell-mediated immune response. Both receptors are ligands of the programmed death receptor PD-1. B7-H1 expression has been detected in the majority of human carcinomas in vivo. B7-H1 mediated signals are able to negatively regulate activated T cell functions and survival, and enable tumor cells to overcome host response. The aim of this study was to investigate the expression of B7-H1 and B7-DC proteins in oral squamous cell carcinomas (OSCC) in vivo. Tissues from 15 samples were cryo-sected and following histological routine staining (HE), incubated with antibodies against human B7-H1 and B7-DC. Immuno-staining of pan-cytokeratin was performed to ascertain the epithelial origin of the tissue and CK 19 to demonstrate the proliferating stage. Confocal laser scanning microscopy confirmed the presence of both B7-H1 and B7-DC in all 15 OSCC. The B7-H1 and B7-DC staining was located in areas of the tissue that were identified as cancerous lesions in the previously stained HE sections before. Staining with Pan-CK and CK19 provided evidence for the epithelial origin and the proliferating stage of the tissue. The in vivo expression of the B7-H1 and B7-DC receptors in oral squamous cell carcinomas suggest that general mechanisms for immune evasion of tumors are also found in OSCC.

  • Groeger, S.; Howaldt, H. P.; Raifer, H.; Gattenloehner, S.; Chakraborty, T.; Meyle, J.

Keywords

  • Adult
  • Aged
  • Antigens, CD274/*metabolism
  • Carcinoma, Squamous Cell/*metabolism
  • Cell Proliferation/physiology
  • Female
  • Humans
  • Ligands
  • Lymphocyte Activation/physiology
  • Male
  • Membrane Glycoproteins/metabolism
  • Middle Aged
  • Mouth Neoplasms/*metabolism
  • Programmed Cell Death 1 Ligand 2 Protein/*metabolism
  • Programmed Cell Death 1 Receptor/metabolism
  • *B7-Dc
  • *B7-h1
  • *Immune evasion
  • *In vivo
  • *Oral squamous cell carcinomas
Publication details
DOI: 10.1007/s12253-016-0100-7
Journal: Pathology oncology research : POR
Pages: 99-110 
Number: 1
Work Type: Original
Location: UGMLC
Disease Area: LC
Partner / Member: JLU
Access-Number: 27498988
See publication on PubMed

DZL Engagements

chevron-down